Belangrijkste concurrenten
Dividendrendement (N) Dividendrendement (N+1) k/w-verhouding (N) Koers-boekwaarde (N) EV/omzet (N) Beurskap. / EBITDA (N) Beurskap. / EBIT (N) Kapi.($)
- - - - - - - 111
0,76%0,85%37.02x26.88x12.25x27.87x30.1x 705 mld.
3,47%3,57%14.44x4.91x4.02x11.08x12.32x 363 mld.
2,73%3,19%18.41x10.63x6.64x13.24x14.63x 331 mld.
3,53%3,7%27.74x45.47x6.38x13.29x13.66x 328 mld.
3,81%3,91%14.17x5.33x3.47x8.61x9.87x 254 mld.
3,4%3,53%16.73x4.96x4.49x10.83x11.69x 228 mld.
2,26%2,38%22.26x4.92x4.16x12.25x12.98x 220 mld.
4,06%4,27%10.16x3.6x3.3x7.11x7.9x 199 mld.
3,31%3,48%21.47x17.24x5.7x11.05x12.91x 156 mld.
7,15%7,3%11.22x1.5x2.79x6.9x7.99x 136 mld.
3,01%3,15%17.91x5.95x5.08x9.27x11.2x 134 mld.
5%5,27%11.08x1.27x2.41x7.79x8.72x 116 mld.
-.--%-.--%29.77x5.78x8.9x18.68x19.63x 115 mld.
5,29%5,47%10.44x4.6x2.77x7.22x7.6x 95,32 mld.
3,28%1,61%27.56x6.05x9.2x18.19x18.92x 83,08 mld.
4,48%4,78%10.07x3.99x2.23x6.59x7.53x 79,09 mld.
0,47%0,55%46.67x6.27x10.16x38.16x40.9x 47,84 mld.
4,52%4,62%51.41x0.95x2.39x9.03x30.58x 46,8 mld.
Gemiddelde 3,36% 3,42% 22,14x 8,91x 5,35x 13,18x 15,51x 191,42 mld.
Gewogen gemiddelde per kap. 2,95% 3,07% 22,42x 13,62x 6,30x 14,60x 16,16x
Farmaceutische producten - Andere